Regeneron Pharmaceuticals
The Senior Associate Scientist in the Assay Development Group at Regeneron develops and optimizes mass spectrometry-based methods to quantify and investigate biologics, siRNAs, and novel antibody conjugates. This role involves generating high-quality data, communicating findings to advance pipeline programs, and collaborating cross-functionally in a fast-paced, science-driven environment. The position requires hands-on laboratory work, data analysis, and maintaining GLP-compliant documentation.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
23% below the average for this role
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Senior Scientist, Analytical Development, Biologics CMC
Exelixis
SCIENTIST, ANALYTICAL DEVELOPMENT AND MASS SPECTROMETRY
Sutro Biopharma
Manager, Bioanalytical Services
ICON plc
Senior Scientist, Quantitative Mass Spectrometry
AstraZeneca
Scientist - BioAnalytical Research
Eli Lilly and Company
Associate Principal Scientist – Bioassay, Cell Based Sciences, AR&D
MSD